(Q38290322)

1 September 2017

title

17beta-Estradiol inhibits cytokine induction of the human E-selectin promoter (English)

1 reference

1 September 2017

Curtis M Tyree

1

1 reference

1 September 2017

Aihua Zou

series ordinal

2

1 reference

1 September 2017

Elizabeth A Allegretto

series ordinal

3

1 reference

1 September 2017

publication date

1 March 2002

1 reference

The Journal of Steroid Biochemistry and Molecular Biology

1 September 2017

published in

1 reference

1 September 2017

volume

80

1 reference

1 September 2017

issue

3

1 reference

1 September 2017

page(s)

291-297

1 reference

The effect of oestrogen on the female cardiovascular system

1 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900022-5

7 January 2021

Sex, plasma lipoproteins, and atherosclerosis: prevailing assumptions and outstanding questions

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900022-5

7 January 2021

The protective effects of estrogen on the cardiovascular system

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900022-5

7 January 2021

Modulation of circulating cellular adhesion molecules in postmenopausal women with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900022-5

7 January 2021

Vascular effects of estrogen and cholesterol-lowering therapies in hypercholesterolemic postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900022-5

7 January 2021

Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900022-5

7 January 2021

Vascular effects of synthetic or natural progestagen combined with conjugated equine estrogen in healthy postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900022-5

7 January 2021

Effects of hormone therapy on inflammatory cell adhesion molecules in postmenopausal healthy women

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900022-5

7 January 2021

Association of circulating cellular adhesion molecules with menopausal status and hormone replacement therapy. Time-dependent change in transdermal, but not oral estrogen users

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900022-5

7 January 2021

Modulation of endothelial cell expression of ICAM-1, E-selectin, and VCAM-1 by beta-estradiol, progesterone, and dexamethasone

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900022-5

7 January 2021

Estradiol enhances leukocyte binding to tumor necrosis factor (TNF)-stimulated endothelial cells via an increase in TNF-induced adhesion molecules E-selectin, intercellular adhesion molecule type 1, and vascular cell adhesion molecule type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900022-5

7 January 2021

Effects of 17beta-estradiol on cytokine-induced endothelial cell adhesion molecule expression

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900022-5

7 January 2021

An NF kappa B-like factor is essential but not sufficient for cytokine induction of endothelial leukocyte adhesion molecule 1 (ELAM-1) gene transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900022-5

7 January 2021

Activation of endothelial-leukocyte adhesion molecule 1 (ELAM-1) gene transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900022-5

7 January 2021

Cyclic AMP-independent ATF family members interact with NF-kappa B and function in the activation of the E-selectin promoter in response to cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900022-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900022-5

7 January 2021

Cooperativity between two NF-kappa B complexes, mediated by high-mobility-group protein I(Y), is essential for cytokine-induced expression of the E-selectin promoter

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900022-5

7 January 2021

Three NF-kappa B binding sites in the human E-selectin gene required for maximal tumor necrosis factor alpha-induced expression

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900022-5

7 January 2021

Induction of the E-selectin promoter by interleukin 1 and tumour necrosis factor alpha, and inhibition by glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900022-5

7 January 2021

Estrogen and estrogen receptor antagonists stimulate transcription from the human retinoic acid receptor-alpha 1 promoter via a novel sequence

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900022-5

7 January 2021

Steroid receptor-mediated inhibition of rat prolactin gene expression does not require the receptor DNA-binding domain

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900022-5

7 January 2021

Cloning and characterization of human estrogen receptor beta isoforms

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900022-5

7 January 2021

Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900022-5

7 January 2021

Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900022-5

7 January 2021

Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900022-5

7 January 2021

Estradiol repression of tumor necrosis factor-alpha transcription requires estrogen receptor activation function-2 and is enhanced by coactivators

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900022-5

7 January 2021

Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900022-5

7 January 2021

Increased expression of estrogen receptor-beta mRNA in male blood vessels after vascular injury

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900022-5

7 January 2021

Immunocytochemical demonstration of oestrogen receptor beta in blood vessels of the female rat

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900022-5

7 January 2021

Differentiation between vasculoprotective and uterotrophic effects of ligands with different binding affinities to estrogen receptors alpha and beta

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900022-5

7 January 2021

Estrogen inhibits the vascular injury response in estrogen receptor alpha-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900022-5

7 January 2021

Estrogen inhibits the vascular injury response in estrogen receptor beta-deficient female mice

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900022-5

7 January 2021

Involvement of CCAAT/enhancer-binding protein and nuclear factor-kappa B binding sites in interleukin-6 promoter inhibition by estrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900022-5

7 January 2021

17 beta-Estradiol inhibits expression of human interleukin-6 promoter-reporter constructs by a receptor-dependent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900022-5

7 January 2021

Competition for p300 regulates transcription by estrogen receptors and nuclear factor-kappaB in human coronary smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900022-5

7 January 2021

The role of CBP in estrogen receptor cross-talk with nuclear factor-kappaB in HepG2 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900022-5

7 January 2021

Mutations in the estrogen receptor ligand binding domain discriminate between hormone-dependent transactivation and transrepression

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900022-5

7 January 2021

10.1016/S0960-0760(02)00022-5

Identifiers

DOI

1 reference

1 September 2017

1 reference